Mr. Mathew George heads Regulatory Affairs at Glenmark Life Sciences, where he oversees the regulatory compliance obligations that the organization needs to fulfil. This includes adhering to existing regulatory affairs requirements, keeping track of new & modified compliance status, periodic compliance testing and performing proactive assessments.
He has more than 26 years of rich experience in quality assurance and regulatory affairs. Mathew is responsible for all aspects of business continuity planning and disaster recovery, to safeguard the organization. He brings strong managerial and technical capabilities to Glenmark Life Sciences to ensure that all compliance needs, both domestic and international, are met. His expertise lies in planning, review and submission of new Drug Master Files (DMFs) / registration dossiers for filing with various regulatory agencies.
Past Experience
Prior to joining Glenmark, Mathew was the General Manager, Head of API Regulatory Affairs at Cadila Healthcare.
He joined the industry in 1995 with Shasun Chemicals & Drugs Ltd., where he was Head of Quality Assurance of the Pondicherry manufacturing facility and later handled the CQA and DQA functions. Mathew then moved to Marksans Pharma Ltd. as Head of QA & RA. He was also with Ranbaxy Laboratories Limited & Mylan Laboratories Ltd., where he handled the Regulatory Affairs function.
Education
Mathew is a graduate in Chemistry from Loyola College, Chennai (April 1992) and holds a post-graduate degree in Inorganic Chemistry from I.I.T. Bombay (April 1994).